
|Articles|October 1, 2002
Supplements and Featured Publications
- Cardiorenal Differences Among NSAIDs and Coxibs: Real-World Experience
- Volume 8
- Issue 15 Suppl
Differences Between COX-2-Specific Inhibitors: Clinical and Economic Implications
Author(s)Edmund H. Sonnenblick, MD
Advertisement
Articles in this issue
about 23 years ago
Participating Facultyabout 23 years ago
Cardiorenal Differences Among NSAIDs and Coxibs: Real-World ExperienceNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
2
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
Real-World Safety Signals of Bimekizumab Emerge in New FAERS Analysis
5










































